PREDICTIVE ONCOLOGY INC. (AIPT) financial statements (2020 and earlier)

Company profile

Business Address 2915 COMMERS DRIVE,
EAGAN, MN 55121
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 01250
Cash and cash equivalents 01250
Receivables 11000
Inventory, net of allowances, customer advances and progress billings 00000
Inventory 00000
Other undisclosed current assets 01100
Total current assets: 12351
Noncurrent Assets
Property, plant and equipment 00000
Long-term investments and receivables 11   
Accounts and financing receivable, after allowance for credit loss 11   
Intangible assets, net (including goodwill) 10000
Intangible assets, net (excluding goodwill) 10000
Total noncurrent assets: 21000
TOTAL ASSETS: 44361
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 21225
Accounts payable 00012
Accrued liabilities 11113
Debt 2   1
Derivative instruments and hedges, liabilities 0    
Estimated litigation liability     0
Deferred revenue and credits0000
Contract with customer, liability0
Other undisclosed current liabilities     (0)
Total current liabilities: 41226
Noncurrent Liabilities
Liabilities, other than long-term debt   0  
Accounts payable and accrued liabilities   0  
Other undisclosed noncurrent liabilities     0
Total noncurrent liabilities:   0 0
Total liabilities: 41226
Stockholders' equity
Stockholders' equity attributable to parent, including: 0314(6)
Preferred stock     0
Common stock 00000
Additional paid in capital 6357484530
Accumulated other comprehensive income   0  
Accumulated deficit (63)(55)(47)(40) 
Other undisclosed stockholders' equity attributable to parent 0000(36)
Total stockholders' equity: 0314(6)
TOTAL LIABILITIES AND EQUITY: 44361

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 11011
Revenue, net1011
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(0)(0)(0)(0)
Gross profit: 11001
Operating expenses (8)(8)(7)(5)(7)
Operating loss: (7)(8)(7)(4)(6)
Nonoperating income 0   0
Investment income, nonoperating     0
Other nonoperating income 0    
Interest and debt expense   (0)(0)(0)
Loss from continuing operations before equity method investments, income taxes: (7)(8)(7)(5)(7)
Loss from equity method investments (2)    
Net loss attributable to parent: (9)(8)(7)(5)(7)
Other undisclosed net loss available to common stockholders, basic (1)    
Net loss available to common stockholders, diluted: (10)(8)(7)(5)(7)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (9)(8)(7)(5)(7)
Comprehensive loss: (9)(8)(7)(5)(7)
Other undisclosed comprehensive income, net of tax, attributable to parent   0  
Comprehensive loss, net of tax, attributable to parent: (9)(8)(7)(5)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: